Quarterly report pursuant to Section 13 or 15(d)

OPTIONS, RESTRICTED STOCK UNITS AND WARRANTS (Tables)

v3.21.2
OPTIONS, RESTRICTED STOCK UNITS AND WARRANTS (Tables)
9 Months Ended
Sep. 30, 2021
OPTIONS, RESTRICTED STOCK UNITS AND WARRANTS (Tables) [Line Items]  
Share-based Payment Arrangement, Option, Exercise Price Range [Table Text Block]

The following table presents information related to stock options at September 30, 2021:

 

Options Outstanding

   

Options Exercisable

 
               

Weighted

         
               

Average

   

Exercisable

 

Exercise

   

Number of

   

Remaining Life

   

Number of

 

Price

   

Options

   

In Years

   

Options

 
$ 2.51-5.00       2,539,757       7.2       1,579,427  
  5.01-7.50       1,229,032       4.7       997,757  
  7.51-10.00       203,333       8.0       138,326  
  10.01-12.50       65,000       8.6       50,415  
          4,037,122       6.5       2,765,925  

 

Options Outstanding

   

Options Exercisable

 
               

Weighted

         
               

Average

   

Exercisable

 

Exercise

   

Number of

   

Remaining Life

   

Number of

 

Price

   

Options

   

In Years

   

Options

 
$ 5.00       125,000       6.12       74,998  

 

Share-based Payment Arrangement, Option, Activity [Table Text Block]

A summary of the stock option activity and related information for the Plan for the nine months ended September 30, 2021 is as follows:

 

   

Shares

   

Weighted-Average

Exercise Price

   

Weighted-Average

Remaining

Contractual Term

   

Aggregate

Intrinsic

Value

 

Outstanding at December 31, 2020

    3,568,497     $ 5.59       7.0     $ 110,961  

Grants

    917,000       3.39       10.0     $ -  

Exercised

    (9,375

)

  $ 2.96               -  

Forfeited/expired

    (439,000

)

  $ 6.68               -  

Outstanding at September 30, 2021

    4,037,122     $ 5.20       6.5     $ 938  

Exercisable at September 30, 2021

    2,765,925     $ 5.35       5.3     $ 563  

 

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

The following assumptions were used in determining the fair value of options during the nine months ended September 30, 2021:

 

Risk-free interest rate

    0.77% - 1.30

%

Dividend yield

    0

%

Stock price volatility

    83.70% to 95.98

%

Expected life

 

5 to 6 years

 

Weighted average grant date fair value

  $ 3.39  

 

Risk-free interest rate

    0.05% - 0.25

%

Dividend yield

    0

%

Stock price volatility

    88.57

%

Expected life

 

0.25 – 2 years

 

 

Risk-free interest rate

    0.06% - 0.46

%

Dividend yield

    0

%

Stock price volatility

    88.59

%

Expected life

 

0.59 – 3 years

 

 

Risk-free interest rate

    0.07% - 0.46

%

Dividend yield

    0

%

Stock price volatility

    88.59

%

Expected life

 

1.25 - 3 years

 

 

Schedule of Warrants or Rights, Shares Authorized, by Exercise Price Range [Table Text Block] The following table summarizes information with respect to outstanding warrants to purchase common stock of BioSig Technologies, Inc. at September 30, 2021:
 

Exercise

   

Number

 

Expiration

 

Price

   

Outstanding

 

Date

  $ 4.80       250,000  

February 2025 to July 2026

  $ 6.16       568,910  

November 2027

            818,910    

 

Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]

A summary of the warrant activity for the nine months ended September 30, 2021 is as follows:

 

   

Shares

   

 

Weighted-Average

Exercise Price

   

 

Weighted-Average

Remaining

Contractual

Term

   

 

Aggregate

Intrinsic Value

 

Outstanding at December 31, 2020

    1,446,200     $ 5.44       3.3     $ 1,500  

Grants

    125,000     $ 4.80       5.0          

Expired

    (752,290

)

  $ 5.00       -       -  

Outstanding at September 30, 2021

    818,910     $ 5.74       5.5     $ -  
                                 

Vested and expected to vest at September 30, 2021

    818,910     $ 5.74       5.5     $ -  

Exercisable at September 30, 2021

    818,910     $ 5.74       5.5     $ -  

 

Nonvested Restricted Stock Shares Activity [Table Text Block]

The following table summarizes the restricted stock activity for the nine months ended September 30, 2021:

 

Restricted shares issued as of December 31, 2020

    218,334  

Granted

    301,000  

Vested and issued

    (216,834

)

Forfeited

    (120,000

)

Total

    182,500  
         

Comprised of:

       

Vested restricted shares as of September 30, 2021

    -  

Unvested restricted shares as of September 30, 2021

    182,500  

Total

    182,500  

 

Restricted shares issued as of December 31, 2020

    1,420,716  

Granted

    -  

Issued

    (40,000

)

Forfeited

    (82,716

)

Total

    1,298,000  
         

Comprised of:

       

Vested restricted shares as of September 30, 2021

    658,000  

Unvested restricted shares as of September 30, 2021

    640,000  

Total

    1,298,000  

 

Schedule of Warrants or Rights, Shares Authorized, Exercise Price Range [Table Text Block]

The following table presents information related to warrants (ViralClear) at September 30, 2021:

 

 

Exercise

   

Number

 

Expiration

 

Price

   

Outstanding

 

Date

  $ 5.00       473,772  

November 2027

    10.00       6,575  

May 2025

            480,347    

 

Viral Clear [Member]  
OPTIONS, RESTRICTED STOCK UNITS AND WARRANTS (Tables) [Line Items]  
Share-based Payment Arrangement, Option, Activity [Table Text Block]

A summary of the stock option activity and related information for the ViralClear Plan for the nine months ended September 30, 2021 is as follows:

 

   

Shares

   

Weighted-Average

Exercise Price

   

Weighted-Average

Remaining

Contractual

Term

 

Outstanding at December 31, 2020

    1,527,666     $ 5.00       3.96  

Grants

    -                  

Exercised

    (550,000

)

  $ 5.00          

Forfeited/expired

    (852,666

)

  $ 5.00          

Outstanding at September 30, 2021

    125,000     $ 5.00       7.40  

Exercisable at September 30, 2021

    74,998     $ 5.00       6.62